Envestnet Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.18M | Buy |
55,753
+16,427
| +42% | +$1.06M | ﹤0.01% | 2595 |
|
|
2026
Q1 | $2.22M | Buy |
39,326
+13,792
| +54% | +$898K | ﹤0.01% | 2943 |
|
|
2025
Q4 | $2.05M | Sell |
25,534
-14,640
| -36% | -$984K | ﹤0.01% | 2805 |
|
|
2025
Q3 | $1.96M | Buy |
40,174
+338
| +0.8% | +$20.9K | ﹤0.01% | 2891 |
|
|
2025
Q2 | $2.97M | Sell |
39,836
-15,910
| -29% | -$1.05M | ﹤0.01% | 2537 |
|
|
2025
Q1 | $3.54M | Buy |
55,746
+7,678
| +16% | +$522K | ﹤0.01% | 2366 |
|
|
2024
Q4 | $3.75M | Buy |
48,068
+4,217
| +10% | +$339K | ﹤0.01% | 2300 |
|
|
2024
Q3 | $3.52M | Buy |
43,851
+2,139
| +5% | +$173K | ﹤0.01% | 2326 |
|
|
2024
Q2 | $3.45M | Buy |
41,712
+5,556
| +15% | +$489K | ﹤0.01% | 2274 |
|
|
2024
Q1 | $3.09M | Buy |
36,156
+398
| +1% | +$31.2K | ﹤0.01% | 2304 |
|
|
2023
Q4 | $3.06M | Buy |
35,758
+2,057
| +6% | +$178K | ﹤0.01% | 2207 |
|
|
2023
Q3 | $3.02M | Buy |
33,701
+6,231
| +23% | +$556K | ﹤0.01% | 2129 |
|
|
2023
Q2 | $2.34M | Sell |
27,470
-379,061
| -93% | -$32M | ﹤0.01% | 2180 |
|
|
2023
Q1 | $2.09M | Buy |
406,531
+378,219
| +1,336% | +$30.6M | ﹤0.01% | 2174 |
|
|
2022
Q4 | $2.23M | Buy |
28,312
+1,078
| +4% | +$86.6K | ﹤0.01% | 2087 |
|
|
2022
Q3 | $2.02M | Buy |
27,234
+3,045
| +13% | +$219K | ﹤0.01% | 2091 |
|
|
2022
Q2 | $1.58M | Sell |
24,189
-527
| -2% | -$31.2K | ﹤0.01% | 2255 |
|
|
2022
Q1 | $1.56M | Buy |
24,716
+9,417
| +62% | +$512K | ﹤0.01% | 2358 |
|
|
2021
Q4 | $811K | Sell |
15,299
-890
| -5% | -$54.2K | ﹤0.01% | 2762 |
|
|
2021
Q3 | $1.14M | Sell |
16,189
-2,986
| -16% | -$188K | ﹤0.01% | 2449 |
|
|
2021
Q2 | $1.28M | Sell |
19,175
-11,397
| -37% | -$806K | ﹤0.01% | 2361 |
|
|
2021
Q1 | $3.39M | Buy |
30,572
+748
| +3% | +$92.6K | ﹤0.01% | 1636 |
|
|
2020
Q4 | $3.54M | Buy |
29,824
+5,545
| +23% | +$597K | ﹤0.01% | 1442 |
|
|
2020
Q3 | $2.12M | Buy |
24,279
+8,140
| +50% | +$711K | ﹤0.01% | 1592 |
|
|
2020
Q2 | $1.45M | Buy |
16,139
+2,675
| +20% | +$270K | ﹤0.01% | 1763 |
|
|
2020
Q1 | $1.34M | Buy |
13,464
+3,359
| +33% | +$364K | ﹤0.01% | 1644 |
|
|
2019
Q4 | $1.16M | Buy |
10,105
+511
| +5% | +$61.8K | ﹤0.01% | 1927 |
|
|
2019
Q3 | $1.21M | Buy |
9,594
+4,521
| +89% | +$574K | ﹤0.01% | 1828 |
|
|
2019
Q2 | $610K | Buy |
5,073
+1,221
| +32% | +$120K | ﹤0.01% | 2268 |
|
|
2019
Q1 | $337K | Sell |
3,852
-10,441
| -73% | -$950K | ﹤0.01% | 2547 |
|
|
2018
Q4 | $1.43M | Buy |
+14,293
| New | +$1.5M | ﹤0.01% | 1525 |
|
|
2018
Q3 | – | Sell |
-18,049
| Closed | -$1.62M | – | 1811 |
|
|
2018
Q2 | $1.62M | Sell |
18,049
-7,906
| -30% | -$668K | ﹤0.01% | 880 |
|
|
2018
Q1 | $1.9M | Sell |
25,955
-710
| -3% | -$48.7K | 0.01% | 727 |
|
|
2017
Q4 | $1.55M | Buy |
26,665
+93
| +0.3% | +$4.9K | ﹤0.01% | 1043 |
|
|
2017
Q3 | $1.19M | Sell |
26,572
-2,568
| -9% | -$107K | ﹤0.01% | 1097 |
|
|
2017
Q2 | $1.15M | Buy |
29,140
+3,769
| +15% | +$155K | ﹤0.01% | 1120 |
|
|
2017
Q1 | $1.03M | Buy |
25,371
+225
| +0.9% | +$8.79K | ﹤0.01% | 1212 |
|
|
2016
Q4 | $1.01M | Sell |
25,146
-183
| -0.7% | -$6.9K | ﹤0.01% | 1180 |
|
|
2016
Q3 | $917K | Sell |
25,329
-8
| -0% | -$275 | ﹤0.01% | 1293 |
|
|
2016
Q2 | $735K | Sell |
25,337
-2,750
| -10% | -$83.1K | ﹤0.01% | 1475 |
|
|
2016
Q1 | $982K | Buy |
28,087
+2,658
| +10% | +$85.8K | ﹤0.01% | 1317 |
|
|
2015
Q4 | $820K | Sell |
25,429
-1,097
| -4% | -$35.6K | ﹤0.01% | 1376 |
|
|
2015
Q3 | $857K | Sell |
26,526
-3,373
| -11% | -$127K | ﹤0.01% | 1357 |
|
|
2015
Q2 | $1.24M | Sell |
29,899
-5,631
| -16% | -$237K | 0.01% | 1296 |
|
|
2015
Q1 | $1.6M | Buy |
35,530
+34,937
| +5,892% | +$1.46M | 0.01% | 1086 |
|
|
2014
Q4 | $22K | Hold |
593
| – | – | ﹤0.01% | 1705 |
|
|
2014
Q3 | $21K | Buy |
593
+63
| +12% | +$2.25K | ﹤0.01% | 1859 |
|
|
2014
Q2 | $19K | Buy |
530
+221
| +72% | +$7.38K | ﹤0.01% | 1778 |
|
|
2014
Q1 | $10K | Sell |
309
-341
| -52% | -$13K | ﹤0.01% | 1883 |
|
|
2013
Q4 | $27K | Buy |
650
+263
| +68% | +$10.8K | ﹤0.01% | 1417 |
|
|
2013
Q3 | $15K | Sell |
387
-96
| -20% | -$4.03K | ﹤0.01% | 1562 |
|
|
2013
Q2 | $20K | Buy |
+483
| New | +$19.6K | ﹤0.01% | 1426 |
|
Other funds holding HAE
AI
Envestnet Asset Management's HAE Position: Q2 2026 in Review
Envestnet Asset Management increased its Haemonetics (HAE) stake by 42% in Q2 2026, buying an estimated $1.06M and bringing the position to 55,753 shares worth $4.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2595.
Envestnet Asset Management first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Envestnet Asset Management held 55,753 shares of Haemonetics worth $4.18M as of Q2 2026.
- Envestnet Asset Management bought 16,427 Haemonetics shares in Q2 2026, an estimated $1.06M.
- Haemonetics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2595 holding.
- Envestnet Asset Management first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.